Piermont Valley Acquisition Q2 net loss narrows to $5,402 from $897,045 year earlier

• Piermont Valley Acquisition posted Q2 net loss of $5,402, narrowing from a $897,045 loss a year earlier.
• Operating costs fell to $27,238 from $33,940; dividend income rose to $21,834 from $21,139.
• Cash outside the Trust Account totaled $2,875; working capital deficit was $352,705 as of June 30, 2026.
• Trust Account balance was $2.48 million; $276,521 was outstanding under a non-interest-bearing working capital promissory note.
• Signed a merger agreement with Tigerless Health on April 17, 2026; parties are seeking at least $5 million of PIPE financing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Piermont Valley Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-005097), on August 14, 2026, and is solely responsible for the information contained therein.